Glipizide vs. Glimepiride
See how Glipizide and Glimepiride compare on approved uses, dosing, side effects, and cost.
Key Takeaways
Glipizide and glimepiride are both sulfonylureas that lower blood sugar in type 2 diabetes but differ in dosing frequency and formulation options.
Glipizide comes in immediate-release and extended-release tablets, while glimepiride is available only as a standard tablet taken once daily.
Both drugs carry a risk of low blood sugar and are among the least expensive oral diabetes medications available.
Glipizide vs. Glimepiride Drug Summary
Glipizide
Glipizide is a second-generation sulfonylurea that helps control blood sugar in adults with type 2 diabetes, used alongside diet and exercise. It comes as an immediate-release tablet taken once or twice daily, or an extended-release tablet taken once daily.
Glimepiride
Glimepiride is a sulfonylurea that helps control blood sugar in adults with type 2 diabetes, used alongside diet and exercise. It is taken as a single oral tablet once daily, usually with the first meal, and has no extended-release form.
Glipizide vs. Glimepiride Side Effects
Glipizide
Glimepiride
Glipizide vs. Glimepiride Dosage
Glipizide
Glimepiride
| STAGE | DOSE | WHEN |
| Starting dose | 5 mg once daily | At the start |
| Maximum dose | 5-20 mg once daily | If needed |
| Dose changes | 5 increases | As tolerated |
| STAGE | DOSE | WHEN |
| Starting dose | 1 mg once daily | At the start |
| Maximum dose | 8 mg once daily | If needed |
| Dose changes | 3 increases | As tolerated |
Glipizide
| STAGE | DOSE | WHEN |
| Starting dose | 5 mg once daily | At the start |
| Maximum dose | 5-20 mg once daily | If needed |
| Dose changes | 5 increases | As tolerated |
Glimepiride
| STAGE | DOSE | WHEN |
| Starting dose | 1 mg once daily | At the start |
| Maximum dose | 8 mg once daily | If needed |
| Dose changes | 3 increases | As tolerated |
Glipizide vs. Glimepiride Indications
Glipizide
Glipizide is FDA-approved to improve blood sugar control in adults with type 2 diabetes when diet and exercise alone are not enough. It is not approved for type 1 diabetes or diabetic ketoacidosis. Doctors often choose it when a low-cost, well-established option is needed.
Adjunct to diet and exercise in type 2 diabetes
Available in immediate-release and extended-release forms
Not for type 1 diabetes or diabetic ketoacidosis
Often used when cost is a major concern
Glimepiride
Glimepiride is FDA-approved to improve blood sugar control in adults with type 2 diabetes when diet and exercise alone are not enough. It is not approved for type 1 diabetes or diabetic ketoacidosis. It is often chosen for its simple once-daily dosing schedule.
Adjunct to diet and exercise in type 2 diabetes
Available only as a standard oral tablet
Not for type 1 diabetes or diabetic ketoacidosis
Often used for its once-daily simplicity
Glipizide vs. Glimepiride Pros and Cons
Glipizide
Glipizide has decades of clinical use and comes in both immediate-release and extended-release forms, adding dosing flexibility. Like other sulfonylureas, it carries hypoglycemia and cardiovascular risks, and is not usually a first-line choice given newer options.
Pros
Available in extended-release form for once-daily dosing
Long clinical track record since 1984 FDA approval
Flexible dosing range to fine-tune blood sugar control
Extended-release shell passes through the GI tract predictably
Cons
Extended-release tablets cannot be split or crushed
Two formulations (IR and ER) can create dosing confusion
Higher-end IR dosing requires multiple daily doses
Glimepiride
Glimepiride offers straightforward once-daily dosing and is one of the most affordable sulfonylureas available. It carries the same hypoglycemia and cardiovascular risks as other drugs in its class, and is not recommended in patients with G6PD deficiency.
Pros
Simple single-tablet dosing with no extended-release version needed
Fewer titration steps to reach an effective maintenance dose
FDA approved since 1995 with well-documented safety data
Only four dosage strengths simplify prescribing
Cons
Risk of hemolytic anemia in patients with G6PD deficiency
Must be stopped at least two weeks before delivery in pregnancy
Postmarketing reports of severe allergic reactions like Stevens-Johnson syndrome
Common Symptoms and Related Diseases You Can Explore
Explore a range of common symptoms the Doctronic Symptom Checker can help you understand.